NeoDynamics at largest German breast cancer congress
The MedTech company NeoDynamics AB (publ) showcased its novel biopsy system NeoNavia at the 41[st] Congress of the German Society of Senology, the most important breast cancer congress in the German speaking area when it resumed after a break during the pandemic. Professor Marc Thill presented an update on the PULSE study, involving NeoNavia at the meeting.Apart from Professor Marc Thill’s presentation, NeoNavia was also referred to as a new method for axillary management by PD Dr Ines Gruber from the University Hospital Tübingen. NeoDynamics also participated in the conference, that ended